BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 23680243)

  • 21. Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study.
    Ogassavara J; Dualib PM; Mattar R; Dib SA; de Almeida-Pititto B
    Arch Endocrinol Metab; 2023 Jun; 67(6):e220483. PubMed ID: 37364140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
    Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM
    J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
    Kekäläinen P; Juuti M; Walle T; Laatikainen T
    Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients.
    Lepore G; Bruttomesso D; Bonomo M; Dodesini AR; Costa S; Meneghini E; Corsi A; Nosari I; Trevisan R
    Diabet Med; 2009 Jun; 26(6):602-8. PubMed ID: 19538235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
    Hauffe F; Schaefer-Graf UM; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M
    Diabet Med; 2019 Feb; 36(2):158-166. PubMed ID: 30698863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes.
    Wender-Ozegowska E; Zawiejska A; Ozegowska K; Wroblewska-Seniuk K; Iciek R; Mantaj U; Olejniczak D; Brazert J
    Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):130-5. PubMed ID: 23316799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
    Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
    Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.
    Ranasinghe PD; Maruthur NM; Nicholson WK; Yeh HC; Brown T; Suh Y; Wilson LM; Nannes EB; Berger Z; Bass EB; Golden SH
    J Womens Health (Larchmt); 2015 Mar; 24(3):237-49. PubMed ID: 25713996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
    Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of continuous subcutaneous insulin infusion on quality of life.
    Lukács A; Kiss-Tóth E; Varga B; Soós A; Takác P; Barkai L
    Int J Technol Assess Health Care; 2013 Jan; 29(1):48-52. PubMed ID: 23270655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuous subcutaneous insulin infusion].
    Balsa AM; Neves C; Alves M; Pereira M; Carvalho D; Medina JL
    Acta Med Port; 2011 Dec; 24 Suppl 2():147-56. PubMed ID: 22849898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections.
    Cypryk K; Kosiński M; Kamińska P; Kozdraj T; Lewiński A
    Pol Arch Med Wewn; 2008 Jun; 118(6):339-44. PubMed ID: 18619188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.